BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 6540111)

  • 1. Pharmacokinetics and body distribution of amiodarone in man.
    Plomp TA; van Rossum JM; Robles de Medina EO; van Lier T; Maes RA
    Arzneimittelforschung; 1984; 34(4):513-20. PubMed ID: 6540111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration.
    Plomp TA; Wiersinga WM; Van Rossum JM; Maes RA
    In Vivo; 1987; 1(5):265-79. PubMed ID: 2979794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone and desethylamiodarone concentrations in plasma and tissues of surgically treated patients on long-term oral amiodarone treatment.
    Plomp TA; Hauer RN; Robles de Medina EO
    In Vivo; 1990; 4(2):97-100. PubMed ID: 2129806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution of amiodarone and desethylamiodarone in rats after repeated oral administration of various amiodarone dosages.
    Plomp TA; Wiersinga WM; Maes RA
    Arzneimittelforschung; 1985; 35(12):1805-10. PubMed ID: 4096733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial disposition of amiodarone in the dog.
    Latini R; Connolly SJ; Kates RE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):603-8. PubMed ID: 6827483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution of amiodarone and desethylamiodarone in rats after multiple intraperitoneal administration of various amiodarone dosages.
    Plomp TA; Wiersinga WM; Maes RA
    Arzneimittelforschung; 1985; 35(1):122-9. PubMed ID: 4039141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of amiodarone after intravenous and oral administration.
    Anastasiou-Nana M; Levis GM; Moulopoulos S
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):524-9. PubMed ID: 7174155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens.
    Brien JF; Jimmo S; Brennan FJ; Armstrong PW; Abdollah H
    Drug Metab Dispos; 1990; 18(6):846-51. PubMed ID: 1981527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
    De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
    Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of long-term oral amiodarone therapy.
    Pollak PT; Bouillon T; Shafer SL
    Clin Pharmacol Ther; 2000 Jun; 67(6):642-52. PubMed ID: 10872646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
    Somani P; Simon VA; McManus K
    Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone.
    Shayeganpour A; Hamdy DA; Brocks DR
    Biopharm Drug Dispos; 2008 Apr; 29(3):159-66. PubMed ID: 18161885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after intravenous administration.
    Plomp TA; Wiersinga WM; van Rossum JM; Maes RA
    In Vivo; 1989; 3(1):33-47. PubMed ID: 2519831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of amiodarone.
    Latini R; Tognoni G; Kates RE
    Clin Pharmacokinet; 1984; 9(2):136-56. PubMed ID: 6370540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers.
    Wiedemann I; Peil H; Justus H; Adamus S; Brantl V; Lohmann H
    Arzneimittelforschung; 1985; 35(6):964-9. PubMed ID: 2862877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma concentrations and amiodarone/desethylamiodarone relations in patients subjected to chronic treatment].
    Ortiz M; Gaete L; Asenjo R; Fernández F; Saavedra I
    Rev Med Chil; 1996 Jan; 124(1):77-82. PubMed ID: 8762622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone: a unique antiarrhythmic agent.
    Sloskey GE
    Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue uptake and metabolism of amiodarone after chronic administration in rabbits.
    Kannan R; Miller S; Singh BN
    Drug Metab Dispos; 1985; 13(6):646-50. PubMed ID: 2867865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and absolute bioavailability of epristeride in healthy male subjects.
    Benincosa LJ; Audet PR; Lundberg D; Zariffa N; Jorkasky DK
    Biopharm Drug Dispos; 1996 Apr; 17(3):249-58. PubMed ID: 8983399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.